HomeCompareVSTO vs PFE

VSTO vs PFE: Dividend Comparison 2026

VSTO yields 4.48% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $22.7K in total portfolio value· pulled ahead in Year 9
10 years
VSTO
VSTO
● Live price
4.48%
Share price
$44.63
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.8K
Annual income
$597.22
Full VSTO calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — VSTO vs PFE

📍 PFE pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVSTOPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VSTO + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VSTO pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VSTO
Annual income on $10K today (after 15% tax)
$380.91/yr
After 10yr DRIP, annual income (after tax)
$507.64/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $21,812.27/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VSTO + PFE for your $10,000?

VSTO: 50%PFE: 50%
100% PFE50/50100% VSTO
Portfolio after 10yr
$38.2K
Annual income
$13,427.97/yr
Blended yield
35.16%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

VSTO
Analyst Ratings
14
Buy
10
Hold
Consensus: Buy
Price Target
$40.00
-10.4% upside vs current
Range: $37.00 — $43.00
Altman Z
2.8
Piotroski
6/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VSTO buys
0
PFE buys
0
No recent congressional trades found for VSTO or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVSTOPFE
Forward yield4.48%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$26.8K$49.6K
Annual income after 10y$597.22$26,258.71
Total dividends collected$5.3K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyHold
Analyst price target$40.00$27.50

Year-by-year: VSTO vs PFE ($10,000, DRIP)

YearVSTO PortfolioVSTO Income/yrPFE PortfolioPFE Income/yrGap
1$11,148$448.13$9,153$693.39+$2.0KVSTO
2$12,395$466.90$8,593$849.25+$3.8KVSTO
3$13,748$485.17$8,336$1,066.78+$5.4KVSTO
4$15,214$502.92$8,437$1,384.80+$6.8KVSTO
5$16,799$520.11$9,013$1,875.40+$7.8KVSTO
6$18,511$536.73$10,306$2,680.72+$8.2KVSTO
7$20,360$552.76$12,820$4,101.38+$7.5KVSTO
8$22,353$568.19$17,673$6,826.70+$4.7KVSTO
9← crossover$24,501$583.00$27,543$12,591.86$3.0KPFE
10$26,813$597.22$49,560$26,258.71$22.7KPFE

VSTO vs PFE: Complete Analysis 2026

VSTOStock

Vista Outdoor Inc. designs, manufactures, and markets consumer products in the outdoor sports and recreation markets in the United States and internationally. The company operates through two segments, Sporting Products and Outdoor Products. The Sporting Products segment designs, develops, manufactures, and distributes ammunitions, components, and related equipment and accessories that serves hunters, recreational shooters, federal and local law enforcement agencies, and military. This segment products include ammunition products, such as pistol, rifle, rimfire, and shotshell ammunition, as well as components. The Outdoor Products segment offers gears and equipment that enhances the outdoor experiences of a wide variety of end users, including hunters, hikers, campers, cyclists, skiers, snowboarders, and golfers. This segments products portfolio includes hunting and shooting accessories comprising reloading equipment, clay targets, premium gun care products, hunting arrows, game calls, hunting blinds, and decoys; optics, such as binoculars, riflescopes, game cameras, and telescopes; tactical accessories comprising holsters, duty gear, bags, and packs; personal hydration solutions consist of hydration packs, water bottles, and drinkware; outdoor cooking solutions, including grills, cookware, pellets, and camp stoves; helmets, goggles, footwear, E-bikes, and accessories for cycling, snow sports, action sports, and power sports; audio speakers for outdoor sports; and golf gps devices, laser rangefinders, golf launch monitors and simulators, and other golf technology products. The company sells its products to outdoor enthusiasts, backyard grillers, campers, and athletes, as well as law enforcement and military professionals through a wide variety of mass, specialty, and independent retailers and distributors, as well as consumers through brand's website. Vista Outdoor Inc. was incorporated in 2014 and is headquartered in Anoka, Minnesota.

Full VSTO Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this VSTO vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VSTO vs SCHDVSTO vs JEPIVSTO vs OVSTO vs KOVSTO vs MAINVSTO vs JNJVSTO vs MRKVSTO vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.